FPFT-2216 enhanced the antiproliferative activity of MDM2 inhibitors in vitro (Fig. 3E; Supplementary Fig. S1C–S1E) and induced CK1α degradation and p53 activation in Z-138 tumor xenografts (Supplementary Fig. S3). The gene discussed is CSNK1A1; the disease is neoplasm.